Regeneron Pharmaceuticals, Inc. (REGN)
-NasdaqGS 267.21 
0.24(0.09%) 11:48AM EDT - Nasdaq Real Time Price
| Prev Close: | 266.97 |
|---|
| Open: | 265.79 |
|---|
| Bid: | 267.16 x 100 |
|---|
| Ask: | 267.25 x 100 |
|---|
| 1y Target Est: | 287.06 |
|---|
| Beta: | 0.84 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 265.27 - 269.78 |
|---|
| 52wk Range: | 107.31 - 283.99 |
|---|
| Volume: | 242,381 |
|---|
| Avg Vol (3m): | 1,117,440 |
|---|
| Market Cap: | 25.89B |
|---|
| P/E (ttm): | 35.73 |
|---|
| EPS (ttm): | 7.48 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN)at TheStreet(Mon 10:01AM EDT)
- 2 Healthcare Companies And 1 Consumer Goods Company With Recent Intensive Insider Sellingat Seeking Alpha(Mon 9:51AM EDT)
- Will ASCO Unlock Big Value in This Cancer Drug Class?at Motley Fool(Sat, May 18)
- IBD 50 Stocks Delivering Strong Earnings, Sales Gainsat Investor's Business Daily(Fri, May 17)
- Coverage initiated on Regeneron Pharms by UBSBriefing.com(Fri, May 17)
- A Fundamental, Bottom-Up Approach to Investing in Health Care: Portfolio Manager Finny Kuruvilla Discusses His Strategies with The Wall Street TranscriptWall Street Transcript(Thu, May 16)
- Pepper Snapple Group CEO Sells More Than 67K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Thu, May 16)
- S&P 500 Stocks Farthest Above 50-DMAsat Seeking Alpha(Thu, May 16)
- Sanofi and Regeneron's Latest Partnershipat Motley Fool(Thu, May 16)
- The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis PharmaceuticalsZacks(Thu, May 16)
- 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet(Wed, May 15)
- Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggardat TheStreet(Wed, May 15)
- Sanofi/REGN Commence EnrollmentZacks(Wed, May 15)
- 3 Stocks Underperforming Today In The Drugs Industryat TheStreet(Wed, May 15)
- Cramer: Buy Aqua America, Radian, Regeneron, and These 2 Stocksat Wall St. Cheat Sheet(Wed, May 15)
Key Statistics
| Forward P/E (1 yr): | 44.39 |
|---|
| P/S (ttm): | 16.30 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.91 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.96 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | 2.14 |
|---|
Business Summary
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally.
View More